L-Carnitine
Amino Acid Derivative | Energy & Fat Metabolism
On this page
What is L-Carnitine?
L-Carnitine is a naturally occurring compound the body makes from two amino acids, and it plays a key role in moving fat into cells' energy-producing mitochondria. It's FDA-approved as an injectable medication (Carnitor) for carnitine deficiency and is widely studied for effects on energy metabolism, heart health, and exercise recovery. Research-grade L-Carnitine sold here is intended for laboratory research use only and is not the same product as, and is not a substitute for, an approved prescription medication.
Key terms:
L-Carnitine is a small molecule.
L-Carnitine (levocarnitine) is a naturally occurring amino acid derivative. It carries long-chain fatty acids into mitochondria, the cell's energy factories, for energy production via beta-oxidation. The body makes it from lysine and methionine. It plays critical roles in energy metabolism, particularly in high-energy tissues like heart, brain, and skeletal muscle. It is FDA approved as Carnitor® for primary and secondary carnitine deficiency. Various forms exist: Acetyl-L-Carnitine (ALCAR) for cognitive support, L-Carnitine L-Tartrate (LCLT) for exercise recovery, and Propionyl-L-Carnitine for cardiovascular health. It has been studied extensively, over 200 clinical trials have examined effects on weight management, exercise performance, heart health, cognitive function, and male fertility.
Key research areas
- Maximum bioavailability (100% vs 14-18% oral)
- Rapid onset of action
- Bypasses gut microbiome conversion to TMAO
- Particularly useful for carnitine deficiency states and clinical settings
- Supports fat metabolism and energy production in high-energy tissues
Researched dosing
This table reflects how researchers and clinicians have structured L-Carnitine study and treatment designs, dose ranges from clinical and research settings, presented as reference, not personal usage guidance.
| Phase | Dose | Frequency | Route |
|---|---|---|---|
| Carnitine-deficiency studies | 50 mg/kg/day | Divided doses or continuous | IV |
| Hemodialysis studies | 10-20 mg/kg | Post-dialysis | IV - Slow push |
| Fat-metabolism and performance studies | 500-1500mg | 1-3x weekly | SubQ or IM |
| Critical-illness studies | Up to 300 mg/kg/day | Divided or continuous | IV - Infusion |
Commonly cycled 12 weeks on, 0+ weeks off.
How it works
At the cell level, L-Carnitine research looks at how the compound shuttles fatty acids into mitochondria, the energy-producing parts of the cell, for breakdown into usable energy.
Injectable L-Carnitine delivers the compound directly to circulation, bypassing the limitations of intestinal absorption. This provides immediate availability for fatty acid transport into mitochondria. IV/IM routes are preferred in clinical settings for carnitine deficiency and dialysis patients.
Pharmacokinetics
This chart plots how a research dose of L-Carnitine is absorbed and cleared over time, its multi-day clearance curve reflects data from the FDA-approved injectable medication's label.
- Peak
- 3.5 hr
- Half-life
- 17 hrs
- Cleared
- ~84 hrs
FDA Carnitor Label
Research applications
This section lists the research areas, metabolic and cardiovascular research chief among them, that scientists have studied for L-Carnitine, including its FDA-approved use for carnitine deficiency; research-grade material sold here is intended for laboratory study only, not human use.
Metabolic
FDA-approved indication for primary and secondary carnitine deficiency. Injectable form provides 100% bioavailability for rapid repletion of carnitine stores. FDA-approved for end-stage renal disease patients on hemodialysis (standard protocol 10-20 mg/kg post-dialysis). Direct delivery supports enhanced fatty acid oxidation and energy production, particularly beneficial when combined with exercise protocols.
Cardiovascular
Meta-analysis found L-Carnitine associated with 27% reduction in all-cause mortality, 65% reduction in ventricular arrhythmias, and 40% reduction in angina development in acute myocardial infarction patients.
Recovery
L-Carnitine L-Tartrate supplementation improved perceived recovery and soreness and lowered serum creatine kinase following high-volume exercise challenge.
Dosage reference
- Doses used in research
- 500-1000 mg
- Frequency in studies
- 2-3x weekly
- Handling
- Reconstituted solution, research use only; not for administration
- Timeline reported in studies
- Immediate availability; metabolic effects within days
- Storage
- Room temperature unopened; refrigerate after opening
- Cycle length
- Ongoing for deficiency; 8-12 weeks for performance
- Break between cycles
- Not typically required
Interactions
This list shows which other metabolic-research compounds are studied alongside L-Carnitine, and flags one pairing (thyroid hormone) that calls for extra caution.
Reconstitution & storage
L-Carnitine injectable typically arrives as a ready-to-use sterile solution rather than a powder that needs mixing, so this section covers handling and clarity checks instead of a reconstitution procedure.
- L-Carnitine injectable typically comes pre-mixed as a sterile solution
- Check solution clarity - should be clear and colorless
- Store the reconstituted solution refrigerated (2-8°C), labeled with the date and concentration, for laboratory research use only.
Lyophilized: Room temperature, use within Per manufacturer expiry (unopened)
Reconstituted: 2-6°C, use within Refrigerate after opening
Quality indicators
These are the visual and documentation checks researchers use to confirm an L-Carnitine sample is pure and properly packaged before it goes into a study.
Clear, Colorless Solution - Injectable L-Carnitine should be a clear, colorless to slightly yellow solution with no particles or cloudiness.
Proper Packaging - Should come in sealed sterile vials with proper pharmaceutical labeling, lot number, and expiration date.
Slight Yellow Tint - A very slight yellow color may be acceptable but check manufacturer specifications. Solution should still be clear.
Cloudy or Particulate - Any cloudiness, particles, or precipitates indicate contamination or degradation - do not use.
Damaged Seal - Never use vials with compromised seals or visible damage. Sterility cannot be assured.
What to expect
This timeline summarizes what the research literature reports at each study stage, research context for comparing studies, not a personal-results promise.
100% bioavailability and rapid tissue distribution
Carnitine levels normalized, with energy-related endpoints reported over this window
Reported increases in fat oxidation during exercise with improved recovery
Sustained metabolic effects reported, with body-composition changes in some studies
Safety notes
This section summarizes L-Carnitine's regulatory status and handling notes, including its FDA-approved use for carnitine deficiency, reference context for laboratory researchers, not medical guidance.
- Use caution in hypothyroidism - may inhibit thyroid hormone action
- Monitor if on anticoagulants (warfarin) - may enhance effect
- Renal patients should be monitored for TMA/TMAO accumulation
- FDA-approved as Carnitor® for primary and secondary carnitine deficiency and hemodialysis support
Regulatory status
- Approved by the FDA for at least one indication. That approval applies to regulated pharmaceutical products, not to research-grade material.
- Supplied and described for laboratory research use only, not for human or veterinary use.
References
Comprehensive meta-analysis showing L-Carnitine supplementation significantly decreased body weight (−1.21 kg), BMI (−0.24 kg/m²), and fat mass (−2.08 kg). Non-linear dose-response analysis suggested 2000 mg/day provides maximum effect.
Mayo Clinic meta-analysis found L-Carnitine associated with 27% reduction in all-cause mortality, 65% reduction in ventricular arrhythmias, and 40% reduction in angina development in acute myocardial infarction patients.
L-Carnitine L-Tartrate supplementation for 5 weeks improved perceived recovery and soreness (p=0.021) and lowered serum creatine kinase (p=0.016) following high-volume exercise challenge.